Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Francusevica (Moscow, Russian Federation), M. Lebedeva (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation). Genetic polymorphisms of the renin-angiotensin system: role in patients with sarcoidosis. 1961

Member's Comments

No comment yet.

Related content which might interest you: Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Genetic polymorphisms of renin-angiotensin system and angiogenic factors in NSCLC progression: discovery and validation studies Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Genetic polymorphism of FOXP3 gene in sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 The role of C/T polymorphism of NOS1 gene in COPD pathogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005 Association of clusters of pulmonary function data with SNP polymorphisms in sarcoidosis patients Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Genetic polymorphisms of the antioxidant enzymes and its role in the development of occupational chronic bronchitis Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006 The role of 774C/T, -691C/T and 894G/T polymorphisms of NOS3 gene in development of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 The influence of TNFα gene polymorphism on the therapeutic response in patients with sarcoidosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Investigating the role of IREB2 genetic variants in susceptibility to COPD Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 The functional polymorphisms in the IL-18 gene promoter is associated with the pathogenesis of sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003 Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Source: Eur Respir J 2008; 32: 1004-1008 Year: 2008 Proinflammatory cytokine gene polymorphisms in the prediction of clinical course in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Positive association of PPARG2 and PPARGC1A gene polymorphisms with sarcoidosis susceptibility Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 The role of ADAM33 polymorphisms in two German populations Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006 Presence of Cox2 polymorphisms and susceptibility to sarcoidosis and its evolution Source: Eur Respir J 2007; 30: Suppl. 51, 113s Year: 2007 Effect of genetic polymorphisms of some cytokines and xenobiotic-metabolizing enzymes on the lung function in patients with COPD Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Are there differences in the functional polymorphism of FCGR3A gene between sarcoidosis and tuberculosis?: Preliminary study Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Role of AQP5 polymorphisms in predisposition to asthma Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 The role of genetic polymorphism of NO-synthase in the implementation of the ²atopic march² Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 ACE gene I/D polymorphism and initial disease presentation in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 75s Year: 2003